03 Aug Favourable SVR12 rates with boceprevir or telaprevir triple therapy in HIV÷ HCV coinfected patients
Posted at 00:00h
in
Authored by: Arends JE, van der Meer J. T. M., Posthouwer D, Kortman K, van Assen S, Smit C, van der Valk M., van der Ende M, Schinkel J, Reiss P, Richter C, Hoepelman A. I. M.
In: The Netherlands Journal of Medicine, 2015
http://www.ncbi.nlm.nih.gov/pubmed/26314715